Cargando…

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer

After androgen deprivation therapy, a significant number of prostate cancer cases progress with a therapy-resistant neuroendocrine phenotype (NEPC). This represents a challenge for diagnosis and treatment. Based on our previously reported design of theranostic small-molecule prodrug conjugates (T-SM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez, Paulina, Debnath, Sashi, Chen, Yu-An, Hernandez, Elizabeth, Jha, Preeti, Dakanali, Marianna, Hsieh, Jer-Tsong, Sun, Xiankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967013/ https://www.ncbi.nlm.nih.gov/pubmed/36839802 http://dx.doi.org/10.3390/pharmaceutics15020481

Ejemplares similares

Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
por: Debnath, Sashi, et al.
Publicado: (2022)

Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer
por: Guan, Bing, et al.
Publicado: (2021)

PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
por: Debnath, Sashi, et al.
Publicado: (2022)

Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023)

Neuroendocrine tumor theranostics
por: Ichikawa, Yasushi, et al.
Publicado: (2022)

Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
por: Murce, Erika, et al.
Publicado: (2023)

Small Molecular Prodrug Amphiphile Self-Assembled AIE Dots for Cancer Theranostics
por: Yang, Xing, et al.
Publicado: (2020)

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
por: Wang, Xinning, et al.
Publicado: (2021)

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate
por: Xiao, Dian, et al.
Publicado: (2021)

Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy
por: Wang, Huiyuan, et al.
Publicado: (2017)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

DNA-supramolecule conjugates in theranostics
por: Chen, Kun, et al.
Publicado: (2019)

Conjugated polymer nanomaterials for theranostics
por: Qian, Cheng-gen, et al.
Publicado: (2017)

Cyanine conjugates in cancer theranostics
por: Li, Yang, et al.
Publicado: (2020)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

A novel glutathione-triggered theranostic prodrug for anticancer and imaging in living cells
por: Zhang, Hengrui, et al.
Publicado: (2018)

Theranostics: radionuclide imaging and therapy in neuroendocrine tumours
por: Drake, Brent, et al.
Publicado: (2015)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Small molecules as theranostic agents in cancer immunology
por: Li, Jindian, et al.
Publicado: (2019)

(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
por: Velikyan, Irina
Publicado: (2020)

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer
por: Wang, Xinning, et al.
Publicado: (2022)

The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC
por: Lee, Cheng‐Fan, et al.
Publicado: (2022)

Circular Discovery in Small Molecule and Conjugated Polymer Synthetic Methodology
por: Mayhugh, Amy L., et al.
Publicado: (2022)

The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges
por: Yun, Eun-Jin, et al.
Publicado: (2016)

The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018)

Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy
por: Ye, Mingzhou, et al.
Publicado: (2016)

Utilization of Enzyme-Immobilized Mesoporous Silica Nanocontainers (IBN-4) in Prodrug-Activated Cancer Theranostics
por: Hung, Bau-Yen, et al.
Publicado: (2015)

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics
por: Wen, Xidan, et al.
Publicado: (2023)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Redox-Responsive Heparin–Chlorambucil Conjugate Polymeric Prodrug for Improved Anti-Tumor Activity
por: Andrgie, Abegaz Tizazu, et al.
Publicado: (2019)

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017)

Integrated prodrug micelles with two-photon bioimaging and pH-triggered drug delivery for cancer theranostics
por: Xu, Hong, et al.
Publicado: (2020)

Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H(2)O(2) responsiveness for cancer theranostics
por: Mu, Xueluer, et al.
Publicado: (2023)

Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
por: Banerjee, Shashwat S., et al.
Publicado: (2012)

Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018)

Small-Molecule Theranostic Probes: A Promising Future in Neurodegenerative Diseases
por: Aulić, Suzana, et al.
Publicado: (2013)

Self-Assembly of Small Organic Molecules into Luminophores for Cancer Theranostic Applications
por: Wang, Jing, et al.
Publicado: (2022)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_baaaevpqujsh98osaeg7kckvat